The 2022 revision of the Clinical Practice Guidelines for Pancreatic Cancer-general remarks-

Abstract

The Clinical Practice Guidelines for Pancreatic Cancer were revised and re-published in July 2022, for the first time in 3 years. Revisions were incorporated according to the "Medical Information Network Distribution Service (Minds) Handbook for Clinical Practice Guideline Development 2020," which provides guidance for guideline development under direction of a new committee for revisions including 140 specialists. General remarks, introducing issues on which consensus is considered to have been reached, were placed in the first half of the revised guidelines. In the second half, important debatable clinical issues were carefully selected and 73 clinical questions and 112 statements with algorithms for diagnosis, treatment, chemotherapy and precision medicine for pancreatic cancer were provided. It is of particular significance in this revision that a group including 4 patient and public representatives and 4 health professionals was actively involved in both the development and implementation of the guidelines.